Process
10th Edition
• Author(s)Linda Lane Lilley;
Shelly Rainforth Collins; Julie
S. Snyder
,TEST BANK
Pharmacology and the Nursing Process (10th Edition) –
Inspired Exam Revision Question Bank
Part 1A: Pharmacology Basics
Chapter 1: The Nursing Process and Drug Therapy
Topic: The Nursing Process and Drug Therapy
Subtopics:
• Key Terms
• Overview of the Nursing Process
• Assessment
• Identification of Human Need Statements
• Planning: Outcome Identification
• Implementation
• Evaluation
• Key Points
Original Educational Content: The following questions are
newly written to assess pharmacology concepts and nursing
,clinical judgment. They are not reproduced from any textbook
or publisher test bank.
Question 1 – Multiple Choice (MCQ)
Clinical Scenario
A registered nurse is preparing to administer the first prescribed
dose of an oral angiotensin-converting enzyme (ACE) inhibitor
to a 67-year-old patient newly admitted with hypertension.
During the pre-administration assessment, the nurse notes that
the patient's blood pressure is 92/58 mm Hg, the patient
reports dizziness when standing, and laboratory results show a
serum potassium level of 5.6 mEq/L.
Question Stem
Which nursing action is most appropriate before administering
the medication?
Answer Options
A. Administer the medication as prescribed because the
provider ordered it.
B. Hold the medication and notify the healthcare provider of
the assessment findings.
, C. Encourage the patient to drink additional fluids before
receiving the medication.
D. Administer the medication and reassess blood pressure in
one hour.
Correct Answer
B. Hold the medication and notify the healthcare provider
of the assessment findings.
Comprehensive Rationale
Why B is Correct
The nursing process begins with assessment. Before
administering any medication, the nurse must evaluate current
clinical findings to determine whether administration is safe.
This patient has several findings that increase the risk of
adverse effects from an ACE inhibitor:
• Symptomatic hypotension
• Low blood pressure
• Hyperkalemia
• Increased fall risk
ACE inhibitors decrease angiotensin II production, resulting in: